UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | – | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 48 | -59.3% | 0.00% | – |
| Q3 2020 | $2,000 | -93.8% | 118 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +1500.0% | 118 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 118 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 118 | -11.3% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 133 | -11.3% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 900,148 | $23,512,000 | 8.12% |
| Horton Capital Management, LLC | 383,428 | $10,015,000 | 7.55% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $77,177,000 | 1.89% |
| Phoenix Holdings Ltd. | 897,464 | $22,251,000 | 0.94% |
| SHIKIAR ASSET MANAGEMENT INC | 51,175 | $1,337,000 | 0.61% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $19,284,000 | 0.31% |
| Coastal Bridge Advisors, LLC | 37,000 | $966,000 | 0.31% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $13,828,000 | 0.27% |
| ALGERT GLOBAL LLC | 10,880 | $284,000 | 0.10% |
| BANK HAPOALIM BM | 14,831 | $387,000 | 0.09% |